Literature DB >> 11531735

What is chronic fatigue syndrome? Heterogeneity within an international multicentre study.

A Wilson1, I Hickie, D Hadzi-Pavlovic, D Wakefield, G Parker, S E Straus, J Dale, D McCluskey, G Hinds, A Brickman, D Goldenberg, M Demitrack, T Blakely, S Wessely, M Sharpe, A Lloyd.   

Abstract

OBJECTIVE: We sought to compare the characteristics of patients presenting with chronic fatigue (CF) and related syndromes in eight international centres and to subclassify these subjects based on symptom profiles. The validity of the subclasses was then tested against clinical data.
METHOD: Subjects with a clinical diagnosis of CF completed a 119-item self-report questionnaire to provide clinical symptom data and other information such as illness course and functional impairment. Subclasses were generated using a principal components-like analysis followed by latent profile analysis (LPA).
RESULTS: 744 subjects returned complete data sets (mean age 40.8 years, mean length of illness 7.9 years, female to male ratio 3:1). Overall, the subjects had a high rate of reporting typical CF symptoms (fatigue, neuropsychological dysfunction, sleep disturbance). Using LPA, two subclasses were generated. Class one (68% sample) was characterized by: younger age, lower female to male ratio; shorter episode duration; less premorbid, current and familial psychiatric morbidity; and, less functional disability. Class two subjects (32%) had features more consistent with a somatoform illness. There was substantial variation in subclass prevalences between the study centres (Class two range 6-48%).
CONCLUSIONS: Criteria-based approaches to the diagnosis of CF and related syndromes do not select a homogeneous patient group. While substratification of patients is essential for further aetiological and treatment research, the basis for allocating such subcategories remains controversial.

Entities:  

Mesh:

Year:  2001        PMID: 11531735     DOI: 10.1046/j.1440-1614.2001.00888.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  33 in total

1.  Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome.

Authors:  Martin Steinau; Elizabeth R Unger; Suzanne D Vernon; James F Jones; Mangalathu S Rajeevan
Journal:  J Mol Med (Berl)       Date:  2004-10-14       Impact factor: 4.599

Review 2.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

3.  A Cross Cultural Comparison of Disability and Symptomatology Associated with CFS.

Authors:  Maria Zdunek; Leonard A Jason; Meredyth Evans; Rachel Jantke; Julia L Newton
Journal:  Int J Psychol Behav Sci       Date:  2015

Review 4.  Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.

Authors:  Frank Nm Twisk
Journal:  World J Methodol       Date:  2015-06-26

5.  Classification of myalgic encephalomyelitis/chronic fatigue syndrome by types of fatigue.

Authors:  Leonard A Jason; Aaron Boulton; Nicole S Porter; Tricia Jessen; Mary Gloria Njoku; Fred Friedberg
Journal:  Behav Med       Date:  2010 Jan-Mar       Impact factor: 3.104

6.  Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study.

Authors:  Ian Hickie; Tracey Davenport; Denis Wakefield; Ute Vollmer-Conna; Barbara Cameron; Suzanne D Vernon; William C Reeves; Andrew Lloyd
Journal:  BMJ       Date:  2006-09-01

7.  High levels of type 2 cytokine-producing cells in chronic fatigue syndrome.

Authors:  A Skowera; A Cleare; D Blair; L Bevis; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

Review 8.  Cognitive Dysfunction in Chronic Fatigue Syndrome: a Review of Recent Evidence.

Authors:  Erin Cvejic; Rachael C Birch; Uté Vollmer-Conna
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

9.  Replication of an empirical approach to delineate the heterogeneity of chronic unexplained fatigue.

Authors:  Eric Aslakson; Uté Vollmer-Conna; William C Reeves; Peter D White
Journal:  Popul Health Metr       Date:  2009-10-05

10.  Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome.

Authors:  Otto Erlwein; Steve Kaye; Myra O McClure; Jonathan Weber; Gillian Wills; David Collier; Simon Wessely; Anthony Cleare
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.